{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Anti-obesity", "High-fat diet", "Sasang constitutional medicine", "Yangkyuksanwha-tang"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "31488172", "DateCompleted": {"Year": "2019", "Month": "12", "Day": "30"}, "DateRevised": {"Year": "2020", "Month": "02", "Day": "25"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "09", "Day": "05"}], "Language": ["eng"], "ELocationID": ["246", "10.1186/s12906-019-2669-3"], "Journal": {"ISSN": "1472-6882", "JournalIssue": {"Volume": "19", "Issue": "1", "PubDate": {"Year": "2019", "Month": "Sep", "Day": "05"}}, "Title": "BMC complementary and alternative medicine", "ISOAbbreviation": "BMC Complement Altern Med"}, "ArticleTitle": "Anti-obesity effect of Yangkyuksanwha-tang in high-fat diet-induced obese mice.", "Pagination": {"StartPage": "246", "MedlinePgn": "246"}, "Abstract": {"AbstractText": ["Yangkyuksanwha-tang (YST) is an herbal medicine based on Sasang constitutional medicine (SCM) and is widely used in Korean traditional medicine. The aim of the study was to evaluate the effect of YST on obesity in high-fat diet (HFD)-induced obese mice.", "We induced obesity in C57bl/6\u2009J mice using a HFD, and then orally administered 300\u2009mg/kg YST for 6\u2009weeks. We measured body weight, food efficiency, organ and fat weight, serum biochemical parameters, and obesity-related gene expression, and carried out histological analysis at the end of the experimental period.", "YST significantly reduced the absolute body weight and food efficiency ratio. The serum, aminotransferase, glucose, total cholesterol, triglyceride, and low-density lipoprotein-cholesterol levels were significantly lower in the YST-treated group than in the control group, whereas the high-density lipoprotein-cholesterol level in the YST-treated group was significantly higher. The YST-treated group also showed a significant reduction in regional fatty tissues and the absolute weight of various organs. We also observed a significantly reduced expression of AP2/FABP4, C/EBP-\u03b2, leptin, and SREBP1c/ADD1 mRNA, and significantly increased expression of UCP-2 and adiponectin mRNA in adipose tissue in the YST-treated group. YST also decreased the lipid droplet size and lipid accumulation in the liver, as well as adipocyte size in epididymal adipose tissue. At the dose tested, YST was non-toxic to the liver and kidneys of the mice.", "The results imply that YST has anti-obesity effects in obesity-induced mice. Although the number of experimental animals was limited and the drug effects concern mice, rather than humans, which have different constitutions, the study has valuable implications with respect to the general effects of YST."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Sasang Constitutional Medicine, Daejeon University, 4, Notaesan-ro, Seobuk-gu, Cheonan-si, Chungcheongnam-do, 331-958, Republic of Korea."}], "LastName": "Koh", "ForeName": "Young-Mee", "Initials": "YM"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Sasang Constitutional Medicine, Daejeon University, 4, Notaesan-ro, Seobuk-gu, Cheonan-si, Chungcheongnam-do, 331-958, Republic of Korea."}], "LastName": "Jang", "ForeName": "Soon-Woo", "Initials": "SW"}, {"Identifier": ["0000-0002-5716-540X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Sasang Constitutional Medicine, Daejeon University, 4, Notaesan-ro, Seobuk-gu, Cheonan-si, Chungcheongnam-do, 331-958, Republic of Korea. twahn@dju.kr."}], "LastName": "Ahn", "ForeName": "Taek-Won", "Initials": "TW"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "BMC Complement Altern Med", "NlmUniqueID": "101088661", "ISSNLinking": "1472-6882"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Obesity Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "CCAAT-Enhancer-Binding Protein-beta"}, {"RegistryNumber": "0", "NameOfSubstance": "Cebpb protein, mouse"}, {"RegistryNumber": "0", "NameOfSubstance": "Cholesterol, HDL"}, {"RegistryNumber": "0", "NameOfSubstance": "Leptin"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Sterol Regulatory Element Binding Protein 1"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["administration & dosage", "chemistry"], "DescriptorName": "Anti-Obesity Agents"}, {"QualifierName": ["drug effects"], "DescriptorName": "Body Weight"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "CCAAT-Enhancer-Binding Protein-beta"}, {"QualifierName": ["metabolism"], "DescriptorName": "Cholesterol, HDL"}, {"QualifierName": ["adverse effects"], "DescriptorName": "Diet, High-Fat"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Leptin"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Medicine, Korean Traditional"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred C57BL"}, {"QualifierName": ["drug therapy", "genetics", "metabolism", "physiopathology"], "DescriptorName": "Obesity"}, {"QualifierName": ["administration & dosage", "chemistry"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Sterol Regulatory Element Binding Protein 1"}], "CoiStatement": "The authors declare that they have no competing interests."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "World Health Organization . Obesity and overweight fact sheet. 2018."}, {"Citation": "Lebel A, Kestens Y, Pampalon R, Theriault M, Daniel M, Subramanian SV. Local context influence, activity space, and foodscape exposure in two Canadian metropolitan settings: is daily mobility exposure associated with overweight? J Obes. 2012;2012:912645. doi: 10.1155/2012/912645.", "ArticleIdList": ["10.1155/2012/912645", "PMC3255287", "22254135"]}, {"Citation": "Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health. 2009;9:88. doi: 10.1186/1471-2458-9-88.", "ArticleIdList": ["10.1186/1471-2458-9-88", "PMC2667420", "19320986"]}, {"Citation": "Lenz M, Richter T, Muhlhauser I. The morbidity and mortality associated with overweight and obesity in adulthood: a systematic review. Dtsch Arztebl Int. 2009;106:641\u2013648.", "ArticleIdList": ["PMC2770228", "19890430"]}, {"Citation": "Oh SW, Yoon YS, Shin SA. Effects of excess weight on cancer incidences depending on cancer sites and histologic findings among men: Korea National Health Insurance Corporation Study. J Clin Oncol. 2005;23:4742\u20134754. doi: 10.1200/JCO.2005.11.726.", "ArticleIdList": ["10.1200/JCO.2005.11.726", "16034050"]}, {"Citation": "Li Z, Maglione M, Tu W, Mojica W, Arterburn D, Shugarman LR, et al. Meta-analysis: pharmacologic treatment of obesity. Ann Intern Med. 2005;142:532\u2013546. doi: 10.7326/0003-4819-142-7-200504050-00012.", "ArticleIdList": ["10.7326/0003-4819-142-7-200504050-00012", "15809465"]}, {"Citation": "Kang JG, Park CY. Anti-obesity drugs: a review about their effects and safety. Diabetes Metab J. 2012;36:13\u201325. doi: 10.4093/dmj.2012.36.1.13.", "ArticleIdList": ["10.4093/dmj.2012.36.1.13", "PMC3283822", "22363917"]}, {"Citation": "Kim JY, Pham DD. Sasang constitutional medicine as a holistic tailored medicine. Evid Based Complement Alternat Med. 2009;6:11\u201319. doi: 10.1093/ecam/nep100.", "ArticleIdList": ["10.1093/ecam/nep100", "PMC2741623", "19745007"]}, {"Citation": "Shin SW, Lee S-G, Jang H-J, Ahn KS, Lee E, Koh B-H, et al. Review of experimental and clinical studies on Soyangin (\u5c11\u967d\u4eba) Yanggyeoksanhwa-tang (\u51c9\u8188\u6563\u706b\u6e6f) in Korea since 2000. Orient Pharm Exp Med. 2014;14:291\u2013300. doi: 10.1007/s13596-014-0155-5.", "ArticleIdList": ["10.1007/s13596-014-0155-5"]}, {"Citation": "Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001;24:683\u2013689. doi: 10.2337/diacare.24.4.683.", "ArticleIdList": ["10.2337/diacare.24.4.683", "11315831"]}, {"Citation": "Kim JH, Kim KJ. Experimental study on anti-obesity effect according to inhibitory effect against lipase activity of sasang constitution medicines. J Physiol Pathol Korean Med. 2005;19:710\u2013715."}, {"Citation": "Roh C, Jung U. Screening of crude plant extracts with anti-obesity activity. Int J Mol Sci. 2012;13:1710\u20131719. doi: 10.3390/ijms13021710.", "ArticleIdList": ["10.3390/ijms13021710", "PMC3291987", "22408418"]}, {"Citation": "Zhou J, Xu G, Yan J, Li K, Bai Z, Cheng W, et al. Rehmannia glutinosa (Gaertn.) DC. Polysaccharide ameliorates hyperglycemia, hyperlipemia and vascular inflammation in streptozotocin-induced diabetic mice. J Ethnopharmacol. 2015;164:229\u2013238. doi: 10.1016/j.jep.2015.02.026.", "ArticleIdList": ["10.1016/j.jep.2015.02.026", "25698243"]}, {"Citation": "Kroger D, Carroll FD. Possible mechanism of agricultural gypsum in regulating appetite. J Anim Sci. 1964;23:1011\u20131015. doi: 10.2527/jas1964.2341011x.", "ArticleIdList": ["10.2527/jas1964.2341011x"]}, {"Citation": "Lee IA, Lee JH, Baek NI, Kim DH. Antihyperlipidemic effect of crocin isolated from the fructus of Gardenia jasminoides and its metabolite Crocetin. Biol Pharm Bull. 2005;28:2106\u20132110. doi: 10.1248/bpb.28.2106.", "ArticleIdList": ["10.1248/bpb.28.2106", "16272698"]}, {"Citation": "Lee SJ, Oh PS, Lim KT. Hepatoprotective and hypolipidaemic effects of glycoprotein isolated from Gardenia jasminoides Ellis in mice. Clin Exp Pharmacol Physiol. 2006;33:925\u2013933. doi: 10.1111/j.1440-1681.2006.04466.x.", "ArticleIdList": ["10.1111/j.1440-1681.2006.04466.x", "17002669"]}, {"Citation": "Heymsfield SB, Allison DB, Vasselli JR, Pietrobelli A, Greenfield D, Nunez C. Garcinia cambogia (hydroxycitric acid) as a potential antiobesity agent: a randomized controlled trial. JAMA. 1998;280:1596\u20131600. doi: 10.1001/jama.280.18.1596.", "ArticleIdList": ["10.1001/jama.280.18.1596", "9820262"]}, {"Citation": "Fassina P, Scherer Adami F, Terezinha Zani V, Kasper Machado IC, Garavaglia J, Quevedo Grave MT, et al. The effect of Garcinia cambogia as coadjuvant in the weight loss process. Nutr Hosp. 2015;32:2400\u20132408.", "ArticleIdList": ["26667686"]}, {"Citation": "Lee IS, Kim KS, Kim KH, Park J, Jeong HS, Kim Y, et al. Anti-diabetic and anti-obesitic effects of aqueous extracts of Yangkyuksanhwa-tang and its two major compositions on db/db mice. Biomed Pharmacother. 2016;83:431\u2013438. doi: 10.1016/j.biopha.2016.07.006.", "ArticleIdList": ["10.1016/j.biopha.2016.07.006", "27424324"]}, {"Citation": "Nair AB, Jacob S. A simple practice guide for dose conversion between animals and human. J Basic Clin Pharm. 2016;7(2):27\u201331. doi: 10.4103/0976-0105.177703.", "ArticleIdList": ["10.4103/0976-0105.177703", "PMC4804402", "27057123"]}, {"Citation": "Poobalan AS, Aucott LS, Smith WCS, Avenell A, Jung R, Broom J. Long-term weight loss effects on all cause mortality in overweight/obese populations. Obes Rev. 2007;8:503\u2013513. doi: 10.1111/j.1467-789X.2007.00393.x.", "ArticleIdList": ["10.1111/j.1467-789X.2007.00393.x", "17949355"]}, {"Citation": "Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393\u2013403. doi: 10.1056/NEJMoa012512.", "ArticleIdList": ["10.1056/NEJMoa012512", "PMC1370926", "11832527"]}, {"Citation": "Aune D, Sen A, Norat T, Janszky I, Romundstad P, Tonstad S, et al. Body mass index, abdominal fatness, and heart failure incidence and mortality: a systematic review and dose-response meta-analysis of prospective studies. Circulation. 2016;133:639\u2013649. doi: 10.1161/CIRCULATIONAHA.115.016801.", "ArticleIdList": ["10.1161/CIRCULATIONAHA.115.016801", "26746176"]}, {"Citation": "Calixto JB. Efficacy, safety, quality control, marketing and regulatory guidelines for herbal medicines (phytotherapeutic agents) Braz J Med Biol Res. 2000;33:179\u2013189. doi: 10.1590/S0100-879X2000000200004.", "ArticleIdList": ["10.1590/S0100-879X2000000200004", "10657057"]}, {"Citation": "Hariri N, Thibault L. High-fat diet-induced obesity in animal models. Nutr Res Rev. 2010;23:270\u2013299. doi: 10.1017/S0954422410000168.", "ArticleIdList": ["10.1017/S0954422410000168", "20977819"]}, {"Citation": "Wang CY, Liao JK. A mouse model of diet-induced obesity and insulin resistance. Methods Mol Biol. 2012;821:421\u2013433. doi: 10.1007/978-1-61779-430-8_27.", "ArticleIdList": ["10.1007/978-1-61779-430-8_27", "PMC3807094", "22125082"]}, {"Citation": "Sjostrom L. Review of the key results from the Swedish obese subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery. J Intern Med. 2013;273(3):219\u2013234. doi: 10.1111/joim.12012.", "ArticleIdList": ["10.1111/joim.12012", "23163728"]}, {"Citation": "Boss O, Samec S, Desplanches D, Mayet MH, Seydoux J, Muzzin P, et al. Effect of endurance training on mRNA expression of uncoupling proteins 1, 2, and 3 in the rat. FASEB J. 1998;12:335\u2013339. doi: 10.1096/fasebj.12.3.335.", "ArticleIdList": ["10.1096/fasebj.12.3.335", "9506477"]}, {"Citation": "Kersten S. Mechanisms of nutritional and hormonal regulation of lipogenesis. EMBO Rep. 2001;2:282\u2013286. doi: 10.1093/embo-reports/kve071.", "ArticleIdList": ["10.1093/embo-reports/kve071", "PMC1083868", "11306547"]}, {"Citation": "Bederman IR, Foy S, Chandramouli V, Alexander JC, Previs SF. Triglyceride synthesis in epididymal adipose tissue: contribution of glucose and non-glucose carbon sources. J Biol Chem. 2009;284:6101\u20136108. doi: 10.1074/jbc.M808668200.", "ArticleIdList": ["10.1074/jbc.M808668200", "PMC2649080", "19114707"]}, {"Citation": "Parish S, Offer A, Clarke R, Hopewell JC, Hill MR, Otvos JD, et al. Lipids and lipoproteins and risk of different vascular events in the MRC/BHF heart protection study. Circulation. 2012;125:2469\u20132478. doi: 10.1161/CIRCULATIONAHA.111.073684.", "ArticleIdList": ["10.1161/CIRCULATIONAHA.111.073684", "22539783"]}, {"Citation": "Mora S, Buring JE, Ridker PM, Cui Y. Association of high-density lipoprotein cholesterol with incident cardiovascular events in women, by low-density lipoprotein cholesterol and apolipoprotein B100 levels: a cohort study. Ann Intern Med. 2011;155:742\u2013750. doi: 10.7326/0003-4819-155-11-201112060-00006.", "ArticleIdList": ["10.7326/0003-4819-155-11-201112060-00006", "PMC3233986", "22147713"]}, {"Citation": "Caldwell SH, Oelsner DH, Iezzoni JC, Hespenheide EE, Battle EH, Driscoll CJ. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease. Hepatology. 1999;29:664\u2013669. doi: 10.1002/hep.510290347.", "ArticleIdList": ["10.1002/hep.510290347", "10051466"]}, {"Citation": "Nakamura A, Terauchi Y. Lessons from mouse models of high-fat diet-induced NAFLD. Int J Mol Sci. 2013;14:21240\u201321257. doi: 10.3390/ijms141121240.", "ArticleIdList": ["10.3390/ijms141121240", "PMC3856002", "24284392"]}, {"Citation": "Jang JW, Lim DW, Chang JU, Kim JE. The combination of Ephedrae herba and Coicis semen in Gambihwan attenuates obesity and metabolic syndrome in high-fat diet-induced obese mice. Evid Based Complement Alternat Med. 2018;2018:5614091.", "ArticleIdList": ["PMC6120302", "30210573"]}, {"Citation": "Jo J, Gavrilova O, Pack S, Jou W, Mullen S, Sumner AE, et al. Hypertrophy and/or hyperplasia: dynamics of adipose tissue growth. PLoS Comput Biol. 2009;5:e1000324. doi: 10.1371/journal.pcbi.1000324.", "ArticleIdList": ["10.1371/journal.pcbi.1000324", "PMC2653640", "19325873"]}, {"Citation": "Ma J-Y, Huang D-S, Seo C-S, Lee S-W, Kim J-Y, Shin H-K. Acute toxicity study on Yangkyuksanhwa-tang in mice. J Sasang Constitut Med. 2009;21:131\u2013137."}, {"Citation": "Beck-Nielsen H, Groop LC. Metabolic and genetic characterization of prediabetic states. Sequence of events leading to non-insulin-dependent diabetes mellitus. J Clin Invest. 1994;94:1714\u20131721. doi: 10.1172/JCI117518.", "ArticleIdList": ["10.1172/JCI117518", "PMC294561", "7962519"]}, {"Citation": "Kahn CR. Banting lecture. Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes. 1994;43:1066\u20131084. doi: 10.2337/diab.43.8.1066.", "ArticleIdList": ["10.2337/diab.43.8.1066", "8039601"]}, {"Citation": "DeFronzo RA. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidaemia and atherosclerosis. Neth J Med. 1997;50:191\u2013197. doi: 10.1016/S0300-2977(97)00012-0.", "ArticleIdList": ["10.1016/S0300-2977(97)00012-0", "9175399"]}, {"Citation": "Friedman JE, Dohm GL, Leggett-Frazier N, Elton CW, Tapscott EB, Pories WP, et al. Restoration of insulin responsiveness in skeletal muscle of morbidly obese patients after weight loss. Effect on muscle glucose transport and glucose transporter GLUT4. J Clin Invest. 1992;89:701\u2013705. doi: 10.1172/JCI115638.", "ArticleIdList": ["10.1172/JCI115638", "PMC442905", "1737857"]}, {"Citation": "Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM. Weight-reducing effects of the plasma protein encoded by the obese gene. Science. 1995;269(5223):543\u2013546. doi: 10.1126/science.7624777.", "ArticleIdList": ["10.1126/science.7624777", "7624777"]}, {"Citation": "Maffei M, Halaas J, Ravussin E, Pratley RE, Lee GH, Zhang Y, Fei H, Kim S, Lallone R, Ranganathan S, et al. Leptin levels in human and rodent: measurement of plasma leptin and Ob RNA in obese and weight-reduced subjects. Nat Med. 1995;1(11):1155\u20131161. doi: 10.1038/nm1195-1155.", "ArticleIdList": ["10.1038/nm1195-1155", "7584987"]}, {"Citation": "Morioka T, Asilmaz E, Hu J, Dishinger JF, Kurpad AJ, Elias CF, et al. Disruption of leptin receptor expression in the pancreas directly affects beta cell growth and function in mice. J Clin Invest. 2007;117:2860\u20132868. doi: 10.1172/JCI30910.", "ArticleIdList": ["10.1172/JCI30910", "PMC1994606", "17909627"]}, {"Citation": "Meier U, Gressner AM. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin Chem. 2004;50:1511\u20131525. doi: 10.1373/clinchem.2004.032482.", "ArticleIdList": ["10.1373/clinchem.2004.032482", "15265818"]}, {"Citation": "Li S, Shin HJ, Ding EL, van Dam RM. Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2009;302:179\u2013188. doi: 10.1001/jama.2009.976.", "ArticleIdList": ["10.1001/jama.2009.976", "19584347"]}, {"Citation": "Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun. 1999;257(1):79\u201383. doi: 10.1006/bbrc.1999.0255.", "ArticleIdList": ["10.1006/bbrc.1999.0255", "10092513"]}, {"Citation": "Gregoire FM, Smas CM, Sul HS. Understanding adipocyte differentiation. Physiol Rev. 1998;78:783\u2013809. doi: 10.1152/physrev.1998.78.3.783.", "ArticleIdList": ["10.1152/physrev.1998.78.3.783", "9674695"]}, {"Citation": "Eberle D, Hegarty B, Bossard P, Ferre P, Foufelle F. SREBP transcription factors: master regulators of lipid homeostasis. Biochimie. 2004;86:839\u2013848. doi: 10.1016/j.biochi.2004.09.018.", "ArticleIdList": ["10.1016/j.biochi.2004.09.018", "15589694"]}, {"Citation": "Rosen ED, Walkey CJ, Puigserver P, Spiegelman BM. Transcriptional regulation of adipogenesis. Genes Dev. 2000;14:1293\u20131307.", "ArticleIdList": ["10837022"]}, {"Citation": "Tanaka T, Yoshida N, Kishimoto T, Akira S. Defective adipocyte differentiation in mice lacking the C/EBPbeta and/or C/EBPdelta gene. EMBO J. 1997;16:7432\u20137443. doi: 10.1093/emboj/16.24.7432.", "ArticleIdList": ["10.1093/emboj/16.24.7432", "PMC1170343", "9405372"]}, {"Citation": "Jeong SJ, Yoo SR, Seo CS, Shin HK. Traditional medicine yanggyuksanhwa-tang inhibits adipogenesis and suppresses proliferator-activated receptor-gamma expression in 3T3-L1 cells. Pharmacogn Mag. 2015;11(43):502\u2013508. doi: 10.4103/0973-1296.160456.", "ArticleIdList": ["10.4103/0973-1296.160456", "PMC4522835", "26246724"]}, {"Citation": "Hua X, Yokoyama C, Wu J, Briggs MR, Brown MS, Goldstein JL, et al. SREBP-2, a second basic-helix-loop-helix-leucine zipper protein that stimulates transcription by binding to a sterol regulatory element. Proc Natl Acad Sci U S A. 1993;90:11603\u201311607. doi: 10.1073/pnas.90.24.11603.", "ArticleIdList": ["10.1073/pnas.90.24.11603", "PMC48032", "7903453"]}]}], "History": [{"Year": "2019", "Month": "5", "Day": "12"}, {"Year": "2019", "Month": "8", "Day": "30"}, {"Year": "2019", "Month": "9", "Day": "7", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "9", "Day": "7", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "12", "Day": "31", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "9", "Day": "5"}], "PublicationStatus": "epublish", "ArticleIdList": ["31488172", "PMC6728965", "10.1186/s12906-019-2669-3", "10.1186/s12906-019-2669-3"]}}]}